Transfer RNA-derived small RNAs (tsRNAs) in gastric cancer.
biomarker
gastric cancer
tRFs
tiRNAs
tsRNAs
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
03
2023
accepted:
23
06
2023
medline:
28
7
2023
pubmed:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Transfer RNA-derived small RNAs (tsRNAs) are newly discovered noncoding RNAs (ncRNAs). According to the specific cleavage of nucleases at different sites of tRNAs, the produced tsRNAs are divided into tRNA-derived stress-inducible RNAs (tiRNAs) and tRNA-derived fragments (tRFs). tRFs and tiRNAs have essential biological functions, such as mRNA stability regulation, translation regulation and epigenetic regulation, and play significant roles in the occurrence and development of various tumors. Although the roles of tsRNAs in some tumors have been intensively studied, their roles in gastric cancer are still rarely reported. In this review, we focus on recent advances in the generation and classification of tsRNAs, their biological functions, and their roles in gastric cancer. Sixteen articles investigating dysregulated tsRNAs in gastric cancer are summarized. The roles of 17 tsRNAs are summarized, of which 9 were upregulated and 8 were downregulated compared with controls. Aberrant regulation of tsRNAs was closely related to the main clinicopathological factors of gastric cancer, such as lymph node metastasis, Tumor-Node-Metastasis (TNM) stage, tumor size, and vascular invasion. tsRNAs participate in the progression of gastric cancer by regulating the PTEN/PI3K/AKT, MAPK, Wnt, and p53 signaling pathways. The available literature suggests the potential of using tsRNAs as clinical biomarkers for gastric cancer diagnosis and prognosis and as therapeutic targets for gastric cancer treatment.
Identifiants
pubmed: 37503324
doi: 10.3389/fonc.2023.1184615
pmc: PMC10369188
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1184615Informations de copyright
Copyright © 2023 Gan, Song and Ding.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Oncol. 2022 Apr 29;2022:8777697
pubmed: 35535309
J Cell Physiol. 2020 Feb;235(2):683-690
pubmed: 31286522
Genomics Proteomics Bioinformatics. 2018 Apr;16(2):144-151
pubmed: 29730207
Nat Rev Genet. 2007 Apr;8(4):272-85
pubmed: 17363976
Theranostics. 2021 Jan 1;11(1):461-469
pubmed: 33391486
Signal Transduct Target Ther. 2020 Jun 30;5(1):109
pubmed: 32606362
J Cancer. 2020 Oct 18;11(24):7237-7245
pubmed: 33193887
Cell Death Dis. 2022 May 18;13(5):471
pubmed: 35585048
Genes Dev. 2020 Jan 1;34(1-2):118-131
pubmed: 31831626
Cell. 2015 May 7;161(4):790-802
pubmed: 25957686
Sci Rep. 2017 Feb 21;7:41184
pubmed: 28220888
Cancer Lett. 2019 Jun 28;452:31-37
pubmed: 30905816
Nat Methods. 2015 Sep;12(9):835-837
pubmed: 26214130
Onco Targets Ther. 2020 Oct 28;13:10931-10943
pubmed: 33149609
J Biol Chem. 2019 Nov 8;294(45):16930-16941
pubmed: 31582561
J Cell Mol Med. 2022 Sep;26(18):4768-4780
pubmed: 35957621
BMC Biol. 2014 Oct 01;12:78
pubmed: 25270025
Nucleic Acids Res. 2016 Jul 8;44(W1):W185-93
pubmed: 27179031
Int J Med Sci. 2021 Feb 4;18(7):1570-1579
pubmed: 33746573
Science. 2016 Jan 22;351(6271):397-400
pubmed: 26721680
Nucleic Acids Res. 2015 Jan;43(Database issue):D141-5
pubmed: 25392422
Cell Commun Signal. 2022 May 19;20(1):68
pubmed: 35590368
Front Oncol. 2021 May 13;11:679366
pubmed: 34055648
Cancers (Basel). 2020 Sep 27;12(10):
pubmed: 32992597
Front Oncol. 2022 Apr 28;12:843598
pubmed: 35574338
Front Oncol. 2021 Aug 23;11:723753
pubmed: 34497770
Nat Cell Biol. 2021 Apr;23(4):424-436
pubmed: 33820973
Nat Cell Biol. 2018 May;20(5):535-540
pubmed: 29695786
Cancer Biomark. 2019;25(2):169-176
pubmed: 31104009
Database (Oxford). 2019 Jan 1;2019:
pubmed: 31735953
Nature. 2017 Dec 7;552(7683):57-62
pubmed: 29186115
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cell. 2017 Jun 29;170(1):61-71.e11
pubmed: 28666125
Cancer Res. 2017 Jun 15;77(12):3194-3206
pubmed: 28446464
Plant Cell Physiol. 2018 Jan 1;59(1):e1
pubmed: 29145635
Arch Biochem Biophys. 2020 Sep 15;690:108467
pubmed: 32592804
Database (Oxford). 2018 Jan 1;2018:
pubmed: 29939244
Nucleic Acids Res. 2021 Jan 8;49(D1):D1038-D1045
pubmed: 33068436
Front Oncol. 2021 Aug 23;11:733763
pubmed: 34497772
J Mol Med (Berl). 2022 May;100(5):679-695
pubmed: 35322869
Noncoding RNA. 2017 Jan 04;3(1):
pubmed: 29657274
Nucleic Acids Res. 2020 Jun 19;48(11):6223-6233
pubmed: 32374873
J Proteome Res. 2017 Feb 3;16(2):413-420
pubmed: 27936807
Clin Lab. 2020 Jun 1;66(6):
pubmed: 32538051
Mol Med. 2022 Jun 11;28(1):63
pubmed: 35690737
Biomark Res. 2020 Oct 15;8:52
pubmed: 33072328
Trends Biochem Sci. 2016 Aug;41(8):679-689
pubmed: 27263052
J Cancer. 2021 Apr 2;12(11):3230-3238
pubmed: 33976732
Cell Res. 2017 Nov;27(11):1307-1308
pubmed: 28840860
Stem Cell Res Ther. 2021 Jul 22;12(1):418
pubmed: 34294122
Front Oncol. 2021 Feb 16;10:570916
pubmed: 33665159
Hum Mol Genet. 2017 Jan 15;26(2):293-304
pubmed: 28025327
Cancer Manag Res. 2022 Aug 04;14:2323-2337
pubmed: 35958946
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3816-25
pubmed: 26124144
Nucleic Acids Res. 2021 Jan 8;49(D1):D254-D260
pubmed: 33035346
Nucleic Acids Res. 2018 Jan 4;46(D1):D152-D159
pubmed: 29186503
RNA Biol. 2017 Oct 3;14(10):1364-1373
pubmed: 27892771
Genes Dev. 2009 Nov 15;23(22):2639-49
pubmed: 19933153
Nucleic Acids Res. 2022 Jan 7;50(D1):D421-D431
pubmed: 34755848
Curr Med Chem. 2019;26(31):5849-5861
pubmed: 30678615
RNA Biol. 2020 Aug;17(8):1081-1091
pubmed: 32597311
BMC Bioinformatics. 2015 Nov 04;16:354
pubmed: 26530785
J Hematol Oncol. 2020 Sep 4;13(1):121
pubmed: 32887641